217 related articles for article (PubMed ID: 32513891)
41. Precision Medicine in Oncology Pharmacy Practice.
Saadeh C; Bright D; Rustem D
Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
[TBL] [Abstract][Full Text] [Related]
42. Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials.
Paliard X; Rixe O
Target Oncol; 2019 Dec; 14(6):631-637. PubMed ID: 31595386
[TBL] [Abstract][Full Text] [Related]
43. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
44. Clinical utility of next-generation sequencing in precision oncology.
Hux A; Lewis A; Sachwitz D; Gregory T
JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
[TBL] [Abstract][Full Text] [Related]
45. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
46. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
47. [The breakthrough of personalized medicine, new hopes and new challenges].
Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
[TBL] [Abstract][Full Text] [Related]
48. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
49. Care of self - care by other - care of other: the meaning of self-care from research, practice, policy and industry perspectives.
Godfrey CM; Harrison MB; Lysaght R; Lamb M; Graham ID; Oakley P
Int J Evid Based Healthc; 2011 Mar; 9(1):3-24. PubMed ID: 21332659
[TBL] [Abstract][Full Text] [Related]
50. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
51. The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.
Cummings CA; Peters E; Lacroix L; Andre F; Lackner MR
Clin Transl Sci; 2016 Dec; 9(6):283-292. PubMed ID: 27860319
[No Abstract] [Full Text] [Related]
52. Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic.
Raheem F; Kim P; Grove M; Kiel PJ
Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32182657
[TBL] [Abstract][Full Text] [Related]
53. Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A; Frantzi M; Vlahou A; Merseburger AS; Mischak H
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 28980455
[TBL] [Abstract][Full Text] [Related]
54. Ushering in the next generation of precision trials for pediatric cancer.
DuBois SG; Corson LB; Stegmaier K; Janeway KA
Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
[TBL] [Abstract][Full Text] [Related]
55. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
[TBL] [Abstract][Full Text] [Related]
56. Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling.
Rioth MJ; Thota R; Staggs DB; Johnson DB; Warner JL
J Am Med Inform Assoc; 2016 Jul; 23(4):773-6. PubMed ID: 27026612
[TBL] [Abstract][Full Text] [Related]
57. An integrated clinical and genomic information system for cancer precision medicine.
Jang Y; Choi T; Kim J; Park J; Seo J; Kim S; Kwon Y; Lee S; Lee S
BMC Med Genomics; 2018 Apr; 11(Suppl 2):34. PubMed ID: 29697362
[TBL] [Abstract][Full Text] [Related]
58. An appraisal of drug development timelines in the Era of precision oncology.
Jardim DL; Schwaederle M; Hong DS; Kurzrock R
Oncotarget; 2016 Aug; 7(33):53037-53046. PubMed ID: 27419632
[TBL] [Abstract][Full Text] [Related]
59. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.
Jørgensen JT
Oncologist; 2019 Jul; 24(7):e432-e440. PubMed ID: 30940745
[TBL] [Abstract][Full Text] [Related]
60. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
